Physician

Jamal M. Aljari, M.D.

According to 2025 Medicare claims, Jamal Aljari, M.D. (NPI: 1992773378) practices addiction medicine in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Westmoreland, PA. This provider's primary affiliated billing organization is VALLEY VIEW HEALTH SERVICES,INC (NPI: 1417351594; TIN: 47-1976448) and primary practice location at 15014-1107.

Aljari's data goes back to 2015 and runs through 2024. For example, in 2021, this provider had 52 traditional Medicare patients, billed 186 HCPCS/CPT codes, and received $12,816 in Medicare payments. 2024 Part D data shows 600 prescription claims across 26 beneficiaries totaling $79,462 in drug costs, led by Jardiance (Empagliflozin). 2020 DME data shows 83 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $100,428 to $12,816. Similarly, Part D prescription costs have fallen sharply in recent years, from $290,237 to $79,462. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,261 and ending at $2,562.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$50K$100K2015 Medicare payment: $100,428 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $97,243 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $76,820 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $55,930 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $50,061 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $35,704 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $12,816 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015140987$100,428
20161561,192$97,243
2017176989$76,820
2018157767$55,930
2019103731$50,061
202072534$35,704
202152186$12,816
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$385K$771K2015 Drug cost: $290,237 (USD; Tot_Drug_Cst)2016 Drug cost: $230,604 (USD; Tot_Drug_Cst)2017 Drug cost: $470,414 (USD; Tot_Drug_Cst)2018 Drug cost: $613,843 (USD; Tot_Drug_Cst)2019 Drug cost: $681,396 (USD; Tot_Drug_Cst)2020 Drug cost: $770,840 (USD; Tot_Drug_Cst)2021 Drug cost: $492,616 (USD; Tot_Drug_Cst)2022 Drug cost: $19,419 (USD; Tot_Drug_Cst)2024 Drug cost: $79,462 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151984,932$290,237
20162113,855$230,604
20172576,943$470,414
20182669,297$613,843
20192629,282$681,396
20202458,632$770,840
20212194,742$492,616
202252128$19,419
2023N/RN/RN/R
202426600$79,462

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.5K$3.0K2016 Medicare payment: $1,805 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $824 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,446 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,585 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,018 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R48$1,805
2017N/R15$824
2018N/R32$1,446
2019N/R49$1,585
2020N/R83$3,018
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin20900$17,305
EliquisApixaban23750$14,033
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl57750$2,637
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11330$193
Levothyroxine SodiumLevothyroxine Sodium11990$101

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Jamal M. Aljari, M.D.?

Tedicare shows public-source Medicare data for Jamal M. Aljari, M.D. (NPI 1992773378), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jamal M. Aljari, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jamal M. Aljari, M.D.?

Jamal M. Aljari, M.D. is linked to VALLEY VIEW HEALTH SERVICES,INC (billing NPI 1417351594) in the available physician profile data.

Does Jamal M. Aljari, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.